Free Trial
NYSE:SYK

Stryker Q2 2025 Earnings Report

Stryker logo
$389.65 -2.86 (-0.73%)
Closing price 03:59 PM Eastern
Extended Trading
$389.50 -0.15 (-0.04%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stryker EPS Results

Actual EPS
N/A
Consensus EPS
$3.06
Beat/Miss
N/A
One Year Ago EPS
N/A

Stryker Revenue Results

Actual Revenue
N/A
Expected Revenue
$5.92 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Stryker Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Thursday, July 31, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Stryker? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stryker and other key companies, straight to your email.

About Stryker

Stryker (NYSE:SYK), headquartered in Kalamazoo, Michigan, is a leading global medical technologies company founded in 1941 by Dr. Homer Stryker. Initially known for its innovative hospital bed and mobile frame for medical equipment, the company has grown to serve a broad range of healthcare providers with products and services designed to enhance patient care and operational efficiency.

Stryker operates through three core segments: Orthopedics, MedSurg, and Neurotechnology & Spine. The Orthopedics division focuses on joint replacement, trauma and extremities, and bone cement, delivering implants for hip, knee, shoulder, and extremity reconstruction. The MedSurg segment supplies surgical equipment, endoscopy systems, and communications solutions, while the Neurotechnology & Spine branch offers products for neurological and spinal surgery, including implants, navigation technologies, and surgical instruments.

The company is renowned for its portfolio of advanced medical devices, including robotic surgical systems such as the Mako platform for joint replacement, high-definition endoscopic towers, and hospital infrastructure products like stretchers, beds, and emergency medical equipment. Stryker’s commitment to research and development has led to continual innovation, visible in its minimally invasive surgical tools and digital health solutions that support data-driven clinical decision-making.

With operations in over 100 countries and a workforce spanning multiple continents, Stryker maintains a strong presence across North America, Europe, Asia, and emerging markets. Under the leadership of Chairman and CEO Kevin Lobo, the company continues to expand its global footprint through strategic acquisitions and partnerships, reinforcing its position as a cornerstone in the healthcare industry.

View Stryker Profile

More Earnings Resources from MarketBeat